Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Chelsea Therapeutics International, Ltd. (CHTP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2014 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 2.4% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/03/2014 |
SC 13G/A
| COLUMBIA WANGER ASSET MANAGEMENT LLC reports a |
| 04/08/2013 |
SC 13G/A
| COLUMBIA WANGER ASSET MANAGEMENT LLC reports a 6.4% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 04/10/2012 |
SC 13G/A
| Chelsea Therapeutics International, Ltd. reports a 6.8% stake in CHELSEA THERAPEUTICS INTL LTD |
| 02/14/2012 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a 8.3% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/14/2012 |
SC 13G/A
| Chelsea Therapeutics International, Ltd. reports a 12% stake in CHELSEA THERAPEUTICS INTL LTD |
| 02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/09/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 07/12/2010 |
SC 13G/A
| VENROCK HEALTHCARE CAPITAL PARTNERS LP reports a |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| Visium Asset Management, LP reports a 0% stake in Chelsea Therapeutics International Ltd. |
| 09/28/2009 |
SC 13G/A
| HealthCor Management, L.P. reports a 1.9% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/17/2009 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 9.8% stake in Chelsea Therapeutics International, Ltd. |
| 02/17/2009 |
SC 13G/A
| DAVIDSON KEMPNER PARTNERS reports a 8.5% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/13/2009 |
SC 13G/A
| Visium Asset Management, LP reports a 6.5% stake in Chelsea Therapeutics International Ltd. |
| 02/12/2009 |
SC 13G/A
| Lipschutz Lester E reports a 5.5% stake in Chelsea Therapeutics International, Ltd. |
| 02/14/2008 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0.9% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/14/2008 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC has filed a Schedule 13D for CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/14/2008 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 9.8% stake in 1 CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/14/2008 |
SC 13G/A
| DAVIDSON KEMPNER PARTNERS reports a 8.5% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 01/08/2008 |
SC 13G/A
| Lipschutz Lester E reports a 8.7% stake in Chelsea Therapeutics International, Ltd. |
| 07/17/2007 |
SC 13G/A
| Visium Balanced Fund LP reports a 7.5% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 03/14/2007 |
SC 13G/A
| DAVIDSON KEMPNER PARTNERS reports a 10.3% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/28/2007 |
SC 13G/A
| BALYASNY ASSET MANAGEMENT LLC reports a 3.9% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/26/2007 |
SC 13G/A
| DAVIDSON KEMPNER PARTNERS reports a 10.1% stake in CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/14/2007 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 5.8% stake in Estimated average burden CHELSEA THERAPEUTICS INTERNATIONAL, LTD. |
| 02/14/2007 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC has filed a Schedule 13D for Chelsea Therapeutics International, Ltd. |
| 10/16/2006 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC has filed a Schedule 13D for Chelsea Therapeutics International, Ltd. |
|
|